Researchers at the Federal University of São Carlos (UFSCar) in the state of São Paulo, Brazil, are developing a panel of ...

FDA approves first blood test for Alzheimer's detection. Simple blood draw replaces expensive scans and spinal taps.

The lumipulse blood test brings renewed hope for earlier diagnosis and treatment for millions of people facing the uncertainty of Alzheimer's disease and other dementias.

The FDA greenlit marketing for the first blood test to help diagnose Alzheimer’s disease. Experts believe this will increase access to Alzheimer’s detection and reduce reliance on expensive ...

The test may make it easier to identify whether people with memory and thinking problems have Alzheimer’s or not.

The Lumipulse blood test identifies the presence of amyloid plaques, a hallmark of Alzheimer’s disease that impairs normal brain function.

The test can aid doctors in determining whether a patient’s memory problems are due to Alzheimer’s or a number of other medical conditions that can cause cognitive difficulties.

The FDA said it has issued its first official green light for a blood test to help diagnose Alzheimer’s disease, adding that it can help reduce the need for invasive samples or expensive PET scans.

The Lumipulse Alzheimer's blood test is the first of a new generation of tests that may replace brain scans and spinal taps to detect the disease.

The US Food and Drug Administration has given marketing clearance to a blood test to help diagnose Alzheimer’s disease, making the test the first to get signoff to aid in the early detection of ...

A new blood test test could determine how far Alzheimer's has progressed and could also help confirm whether another condition is causing a person’s cognitive symptoms.

The MCHC blood test measures the concentration of hemoglobin in red blood cells, helping diagnose anemia and other blood disorders.